Loading
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (17 ops.)
Latest filing published 24 Mar 2025 for Knight Therapeutics Inc., €10.1M.
Filing timeline
BuySaleSime Armoyan
Insider track record
Disclosed buys
15
Disclosed sells
17
Signal history
Sime Armoyan: trading record in brief
All filings by Sime Armoyan on record concern Knight Therapeutics Inc. We count 33 filings; the first trade dates from 14 June 2022 and the latest from 21 March 2025.
Both buying and selling appear: 15 purchases worth €2.0M, against 17 sales worth €13.5M. Taken together, the sales exceed the purchases by €11.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: no purchases and 11 sales on the market.
In size, the median ticket on the buying side is €55k. None of the 8 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 24 March 2025: an open-market sale of €10.1M, in Knight Therapeutics Inc. The most recent open-market purchase was published on 25 March 2024, 943 days ago. Filings reach the SEDI feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sime Armoyan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
2,500,000 shares@ CA$6.3083.4% of flowCommon SharesTSXSEDI:4479819
50,000 shares@ CA$6.401.7% of flowCommon SharesTSXSEDI:4478354
76,600 shares@ CA$6.35812.6% of flowCommon SharesTSXSEDI:4478353
5,300 shares@ CA$6.250.2% of flowCommon SharesTSXSEDI:4476631
70,000 shares@ CA$6.002.2% of flowCommon SharesTSXSEDI:4475990
92,200 shares@ CA$6.153.0% of flowCommon SharesTSXSEDI:4475991
100,000 shares@ CA$6.153.2% of flowCommon SharesTSXSEDI:4474576
1,100 shares@ CA$6.100.0% of flowCommon SharesTSXSEDI:4474189
92,900 shares@ CA$6.11173.0% of flowCommon SharesTSXSEDI:4474188
17,600 shares@ CA$5.750.5% of flowCommon SharesTSXSEDI:4474187
7,800 shares@ CA$6.150.3% of flowCommon SharesTSXSEDI:4474577
15,000 shares@ CA$5.950.4% of flowCommon SharesTSXSEDI:4311136
10,900 shares@ CA$5.950.3% of flowCommon SharesTSXSEDI:4300711
7,300 shares@ CA$5.24070.2% of flowCommon SharesTSXSEDI:4285895
Canonical exit: 19 Jun 2024 (T+90)
351,000 shares@ CA$5.259.0% of flowCommon SharesTSXSEDI:4285900
Canonical exit: 23 Jun 2024 (T+90)
28,200 shares@ CA$5.750.9% of flowCommon SharesTSXSEDI:4246980
91,000 shares@ CA$5.752.8% of flowCommon SharesTSXSEDI:4246518
3,000 shares@ CA$4.35Common SharesTSXSEDI:4189764
Canonical exit: 26 Dec 2023 (T+90)
50,000 shares@ CA$4.35Common SharesTSXSEDI:4189760
Canonical exit: 25 Dec 2023 (T+90)
29,900 shares@ CA$4.3718Common SharesTSXSEDI:4189758
Canonical exit: 25 Dec 2023 (T+90)
21,500 shares@ CA$4.3952Common SharesTSXSEDI:4186962
Canonical exit: 20 Dec 2023 (T+90)
5,800 shares@ CA$4.3999Common SharesTSXSEDI:4186964
Canonical exit: 24 Dec 2023 (T+90)
13,200 shares@ CA$4.3575Common SharesTSXSEDI:4186961
Canonical exit: 19 Dec 2023 (T+90)
2,800 shares@ CA$4.395Common SharesTSXSEDI:4186963
Canonical exit: 21 Dec 2023 (T+90)
18,000 shares@ CA$4.37320.4% of flowCommon SharesTSXSEDI:4185293
Canonical exit: 18 Dec 2023 (T+90)
25 of 33 declarations
